Patellofemoral pain (PFP) is a common and recurrent knee condition in young females, characterized by pressure hyperalgesia and reduced pain inhibitory control. This study investigated antinociceptive and pronociceptive profiles in young females with longstanding (.5 years) PFP (current-PFP), those who recovered from adolescent PFP (recovered-PFP), and pain-free controls. This preregistered, assessor-blinded, cross-sectional study included 87 females younger than 25 years: 36 current-PFP, 22 recovered-PFP, and 29 pain-free controls. The primary outcome was conditioned pain modulation (CPM) assessed by increase of cuff pain thresholds during painful cuff conditioning on the contralateral leg. Secondary outcomes included pressure pain thresholds at the knee, shin, and forearm, and temporal summation of pain, assessed by pain intensity recordings on a visual analogue scale during repeated cuff pressure pain stimulations on the leg. Compared with the recovered-PFP, the current-PFP had impaired CPM (mean difference: 11.6%; P 5 0.004) and reduced pressure pain thresholds at the knee, shin, and forearm which were also reduced compared to current-PFP (mean difference: 85-225 kPa; P , 0.05). There were no differences between current-PFP and controls in CPM. Current-PFP and recovered-PFP demonstrated facilitated temporal summation of pain, compared to controls (mean difference: 0.7-0.8 visual analogue scale change; P , 0.05). Compared with controls, the recovered-PFP also had reduced pressure pain thresholds at the knee, which were higher than the current-PFP (mean difference: 110-225 kPa; P , 0.05). In conclusion, both current-PFP and recovered-PFP displayed altered pain mechanisms compared to controls with no history of knee pain, despite resolution of symptoms in the recovered-PFP group. The implications of these findings in the recurrent nature of PFP requires further studies.
Introduction
Knee pain is common in youth, with patellofemoral pain (PFP) being the most common knee pain condition, affecting 1 in 14 adolescents with a prevalence twice as high in females. 6, 7, 24, 29 Patellofemoral pain is associated with decreased quality of life and reduced physical activity due to pain. 29 Patellofemoral pain is a persistent and recurrent condition, with up to 50% of adolescents reporting pain 1 27 and 2 years 29 after being offered evidence-based treatment. The reasons underlying pain recurrence are unknown. In other recurrent musculoskeletal pain conditions such a low back pain 11 and adolescents with musculoskeletal pain, 12 ,36 a previous history of pain is associated with an increased risk of new pain episodes. Previous research has not been able to explain this, but one hypothesis is involvement of neuroplasticity of central pain mechanisms during pain-free periods.
Individuals with PFP have been characterized by lower pressure pain thresholds around the knee, at the tibialis anterior muscle, and the elbow, indicating widespread hyperalgesia. 28, 32, 33, 38 Widespread hyperalgesia is common in other painful knee disorders such as severe knee osteoarthritis, 4, 5 and indicates the spreading of sensitisation beyond the local painful area, 3 and facilitation of central pain mechanisms may be implicated. Temporal summation of pain (TSP) and conditioning pain modulation (CPM) are 2 psychophysical tests, often used to evaluate pronociceptive and antinociceptive central mechanisms, respectively. Facilitated TSP, evaluated as the change in pain response to subsequent stimuli of the same intensity, is believed to represent central pain facilitation when integrating the incoming nociception. 2 Conditioning pain modulation is thought to reflect descending inhibition at the brainstem level, 21 although it may be considered the net effect of pain inhibitory and facilitatory mechanisms in the descending pain control system. It is evaluated by changes in perception of test stimuli from before to during application of a painful conditioning stimuli. 40, 41 Despite
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these mechanisms are altered in chronic and recurrent musculoskeletal pain conditions, including knee osteoarthritis and low back pain, 3, 5, 18 only one explorative study in female adolescents with PFP demonstrated impaired CPM response relative to controls, 28 and the question remains as to how these mechanisms behave during recovery. It is unclear whether the central pain mechanisms return to the level of healthy controls when pain-free, or whether some degree of sensitisation may be present even when recovered.
The aim of this study was to compare CPM, TSP, as well as localised and widespread pain sensitivity in young females: (1) with current long-standing PFP (current-PFP), (2) self-reported as "recovered" but with a history of adolescent PFP (recovered-PFP), and (3) without pain. It was hypothesised that in comparison with current-PFP, both recovered-PFP and pain-free controls would demonstrate more efficient CPM, higher pressure pain thresholds, and less facilitated TSP. It was further hypothesized that recovered-PFP would have impaired CPM and decreased pressure pain thresholds and facilitated TSP compared with painfree controls.
Methods

Participants
This study was preregistered (ClinicalTrials.gov: NCT03051412), and designed as an assessor-blinded, matched cross-sectional study of 3 groups: (1) Young female adults with a history of longstanding PFP (.5 years), (2) age-matched females with a history of adolescent PFP who currently self-report as recovered, and (3) age-matched female controls with no history of pain. The primary outcome in this study was CPM; based on detecting a mean difference in CPM response of 36% between PFP and controls, with common SD of 50% (corresponding to an effect size of 0.72) 28 and power of 85%, the sample size equation was used to estimate inclusion of 36 young female adults in each group.
All participants were recruited from the Adolescent Pain in Aalborg 2011 cohort (APA2011), 31 a population-based cohort that included adolescents from schools in Aalborg. The APA2011 cohort consists of 504 adolescents with knee pain, of whom 151 were diagnosed with PFP by a rheumatologist in 2011, and 250 adolescents from the same schools' population with no musculoskeletal pain at inclusion. The 5-year follow-up of this prospective cohort was conducted in September 2016 (NCT02873143). In September 2016, participants were contacted and requested to fill out an online questionnaire regarding current pain. From this questionnaire, a list of potentially eligible participants for the current investigation was generated as follows: current-PFP were randomly contacted from those diagnosed with PFP at baseline, and reporting knee pain in both the previous week and month in September 2016; participants potentially eligible as recovered-PFP were selected from those diagnosed with PFP at baseline, reporting "No" to knee pain in both the previous week and month. For this study, the control group was selected from those who had no knee pain at baseline (2011), or at five-year follow-up. To eliminate selection bias, participants from each of these groups were randomly selected to be invited to participate, by assigning them an ID number, and sequentially selecting IDs to invite using a random number generator (Excel).
The inclusion criteria applied at the time of testing in 2016 for the current-PFP group were: current anterior knee or retropatellar pain since adolescence of insidious onset; pain provoked by at least 2 of the following knee loading activities: squatting, running, hopping, or stair walking 10 
Self-reported measures
In addition to height, weight, and age, the following clinical selfreported measures were collected from participants during the physical assessment of eligibility: (1) Knee Injury and Osteoarthritis Outcome Score with scores ranging from 0 (worst) to 100 (best) and covering the 5 domains: pain, symptoms, function in daily living, function in sport and recreation, and knee-related quality of life; 34 (2) Numerical Rating Scale scores of worst pain intensity during the last week and average pain last week; (3) pain frequency of knee pain; (4) symptom duration (from recall); (5) if they no longer suffered from knee pain, the symptom-free duration (from recall); and (6) the pain localisation collected by the Navigate Pain (Aglance Solution, Aalborg, Denmark) application, 8 as well as unilateral or bilateral pain (if bilateral pain was indicated, participants were asked to indicate the most painful knee), and pain in other locations.
Protocol
Participants were assessed using a quantitative sensory testing (QST) battery. Participants were familiarised with procedures on the day of testing, with standardised instructions given to all participants by a native Danish speaker. Instructions and procedures were pilot-tested for comprehensibility with 10 healthy individuals before recruitment of the first participant. If the tester for some reason believed the instructions were not understood, they were explained again until the tester was confident in the participants' understanding. The testing session took approximately 30 minutes per participant. The assessor performing assessments was blinded to group allocation (current-PFP, recovered-PFP, or control).
The protocol included assessment of CPM (primary outcome), as well as TSP and pressure pain thresholds as secondary outcomes (outlined in detail below). These methods have demonstrated reliability, 16, 17 and collection of outcomes followed the same approach as previously. 28 For the current-PFP group, the leg with knee pain or the "most painful knee" was selected as the test leg for those who had bilateral pain. The same method was used for the recovered-PFP group who reported a history of bilateral pain. Control participants were randomly assigned a leg to act as the test leg. To ensure blinding, 2 assessors were present for all participants: One who was unblinded to group status greeted participants, explained the procedure, obtained informed consent and collected the selfreport data (which was used to assign the test leg), before participants were introduced to a second assessor who conducted the algometry measures. The success of the blinding was calculated by asking the experimenter to guess which group the participants belonged to (current-PFP, recovered-PFP, or controls). If group status was adequately concealed, it would be likely that a correct guess would be made 33% of the time. All participants were tested in the same sequence ( Fig. 1) , first with pressure pain threshold assessed by pressure algometry at the knee, shin, and elbow, and subsequently, assessment of leg pain sensitivity to cuff pressure detection and tolerance thresholds, TSP, and CPM by cuff algometry.
Single-point pressure pain sensitivity
Pressure pain thresholds were assessed using a handheld algometer (Somedic, Hörby, Sweden) with a 1-cm 2 probe (covered by a disposable latex sheath). The pressure algometer was placed perpendicular to the skin and pressure was manually increased at a rate of 30 kPa/s. Participants were instructed to indicate when the sensation first changed from a sensation of pressure to a sensation of pressure pain. The participant was fitted with a handheld switch and instructed to press the switch as soon as the pressure triggered pain. This was done on the following sites: (1) on the knee at the centre of the patella on the test leg; 32 (2) on the tibialis anterior muscle 5 cm distal to the tibial tuberosity on the test leg; and (3) on the contralateral elbow, on the lateral epicondyle of the humerus.
Cuff pressure pain sensitivity
A computer-controlled cuff pressure algometer 16, 17 (NociTech, Aalborg, Denmark) with an air-filled tourniquet cuff (VBM, Sulz, Germany) was used to assess the cuff pressure detection threshold and pressure tolerance threshold. The cuff was applied just below the heads of the gastrocnemius muscle and the pressure was increased automatically at a rate of 1 kPa/s to a maximum of 100 kPa. Subjects were instructed to rate the first onset of pain, and continuously thereafter, using an electronic 10-cm visual analogue scale (VAS; "0 cm" representing "no pain" and "10 cm" representing "maximal pain"), and to push a handheld switch when they could no longer tolerate the pressure (defined as pressure tolerance threshold). If tolerance was not reached before 100 kPa, the pressure tolerance threshold was defined as 100 kPa for the further analysis. The cuff pain detection threshold was defined as the cuff pressure when the VAS was 1 cm. 17 This procedure was repeated bilaterally. Cuff algometry is considered reliable with interclass coefficients of 0.79 to 0.87. 17 
Temporal summation of pain
The computer-controlled cuff algometer (NociTech) was used to assess TSP. Ten short-lasting stimuli (1 second each) at the level of the cuff pressure tolerance threshold were given with a 1-second break in between stimuli. Participants were instructed to continuously rate the pain intensity of these sequential 10 stimuli using the electronic VAS, and not to return to zero in the breaks. For each cuff stimulus, a VAS score was extracted and the 10 VAS scores were normalised by subtracting the VAS score of the first stimulus. For analysis of TSP, the average VAS score was calculated in the interval from the first to the fourth VAS score (VAS-I) and for the final 3 VAS scores (VAS-II). The TSP effect was defined as the difference between VAS-I and VAS-II (ie, VAS-II minus VAS-I), which has been used in similar studies previously. 26 This method has demonstrated reliability (VAS I-II interclass coefficients 0.7-0.77). 37 
Conditioning pain modulation
Conditioning pain modulation was assessed by the change in cuff pressure pain sensitivity at the leg, from baseline (outlined above) to during the presence of a painful conditioning stimulus applied to the contralateral leg, by cuff algometry. This method has proven reliable. 16 The conditioning stimulus was induced by inflation of a tourniquet around the lower leg contralateral to the test leg at a pressure level corresponding to 70% of the pressure tolerance threshold. This was inflated immediately at the beginning of the test to hold this constant pressure, while simultaneously the cuff on the test leg began to inflate at a rate of 1 k/Pa to reassess the pain detection and tolerance thresholds. Both tourniquets began simultaneously and were released once all measurements were finished, or if the subject terminated the collection of outcomes using the hand switch (maximum 100 seconds). The CPM effect was calculated as the percentage change in pressure detection and tolerance thresholds from baseline, compared with the recordings during the conditioning stimulus (ie, a positive CPM effect indicates an efficient CPM). 41 Participants were excluded from this analysis if pressure tolerance was not reached before 100 kPa, as a CPM response would not be detectable. 
Statistics
Data are presented as mean and SD or median and interquartile range unless otherwise stated. All data were assessed for approximate normal distribution by visual inspection of Q-Q plots. The primary analysis was performed using a 1-way analysis of variance (ANOVA) with the categorical dependent variable as group (current-PFP, recovered-PFP, and control). The dependent variables were CPM effect (on both pressure detection and tolerance thresholds), TSP, and pressure pain thresholds (knee, tibia, and elbow).
In addition to comparing differences in CPM effect across groups, a repeated-measures ANOVA was run with factors time (baseline vs conditioning) and groups (current-PFP, recovered-PFP, and control) to validate whether the conditioning paradigm induced CPM in the groups (ie, had a significant increase in pain detection threshold and pain tolerance threshold from baseline).
For cuff pain sensitivity (pressure detection and tolerance thresholds), a 2-way between-within subject ANOVA was run, with the categorical dependent factor as group (current-PFP, recovered-PFP, and control), and the within-subjects factors as side (test leg and contralateral leg). With significant factors or interactions, the least significant difference post hoc tests were used. Secondary analyses were performed using Pearson correlation to explore the association between duration of recovery and local pain sensitivity (pressure pain threshold at the centre of the patella). Statistical significance was set at P , 0.05.
Results
Eighty-seven young females were recruited, tested, and included in analysis of QST measures. Thirty-six in the current-PFP group, 22 in the recovered-PFP group, and 29 controls. Current-PFP had a median pain duration of 8 years, whereas those who no longer experienced knee pain were recovered for a median of 2 years (participant demographics for each group outlined in Table 1 ). The assessor blinding was considered reasonable, with the blinded assessor guessing correctly identified correct allocation for 49% of the participants in the correct group. All participants completed all QST procedures.
In the current-PFP group, 33 of 36 participants completed the pain drawings. Participants with current-PFP had a median of 2 (IQR 1-2.5) pain sites (all including knee pain), with 60% reporting pain in another location than the knee, most commonly back (N 5 11), neck (N 5 7), and hip/pelvis (N 5 7) pain. Seven of the 33 fulfilled the American College of Rheumatology criteria for widespread pain. 39 
Conditioning pain modulation
Two participants (one current-PFP and one control) reached the 100 kPa limit (both on the test and contralateral legs) and were excluded from the CPM analysis. A significant group effect was found for the CPM effect assessed by the percentage increase in pressure tolerance threshold ( Fig. 2 ; ANOVA: F(2,84) 5 4.402; P , 0.05). Post hoc test revealed that those with current-PFP pain had a reduced CPM effect relative to the recovered-PFP In the repeated-measures ANOVA, to determine which groups had a significant increase in pressure detection and tolerance thresholds from baseline, there was a significant interaction for both pressure detection (F(4.2,2); P , 0.05) and tolerance thresholds (F(8.0,2); P , 0.05). All 3 groups had a significant increase in both detection and tolerance thresholds from baseline (P , 0.05; Table 2 ) ie, pain inhibition was present despite the between-group differences in how much CPM the groups demonstrated (CPM effect).
Temporal summation of pain
Mean VAS scores normalised relative to the first stimulation for each group over the 10 repeated stimulations are displayed in Figure 3 . The ANOVA of TSP-effect showed a difference between groups (F(2,84) 5 5.0; P , 0.05). Post hoc testing revealed the current-PFP group had a facilitated TSP effect (1.7 cm, 95% CI 1.3-2.2 cm) compared with controls (0.9 cm, 95% CI 0.5-1.3 cm; mean difference 5 0.8 cm; 95% CI 0.3-1.4 cm; P , 0.01) but not when compared with the recovered-PFP (1.6 cm, 95% CI 1.2-2.0 cm; mean difference 5 0.1 cm; 95% CI 2 0.7 to 0.6 cm; P 5 0.5). Similarly, the recovered-PFP showed facilitated TSP compared with pain-free controls (mean difference 0.7 cm; 95% CI 0.08-1.4 cm; P , 0.05).
Cuff pressure pain sensitivity
There was a significant main effect for group for pressure tolerance threshold (F(2,84) 5 4.818, P , 0.01). The current-PFP group had reduced pressure tolerance threshold compared with both the recovered-PFP (P , 0.029) and the pain-free controls (P , 0.01). Main effects for pressure detection and tolerance threshold are presented in Table 3 . No significant group effect was found for the pressure detection threshold (F(2,84) 5 1.285, P 5 0.12).
Single-point pressure pain sensitivity
There were significant differences between groups for pressure pain thresholds at the centre of patella (ANOVA: F (2,84) 5 13.6; P , 0.001), the tibialis anterior muscle (ANOVA: F(2,84) 5 6.5; P , 0.002), and the contralateral elbow (ANOVA: F(2,84) 5 3.1; P , 0.049). Post hoc analysis demonstrated that the current-PFP group had lower pressure pain thresholds at the knee compared with both the recovered-PFP group (P , 0.05) and the control group (P , 0.0001), and lower pressure pain thresholds at the tibialis anterior muscle and contralateral elbow compared with the control group (P , 0.001; Table 3 ). The recovered-PFP group had lower pressure pain thresholds at the knee compared with controls (P , 0.027).
Pain sensitivity and time since recovery
Pearson correlation was run to determine whether there was any association between local pain sensitivity (pressure pain threshold at centre of patella) and time since recovery in the recovered group. There was no significant relationship between the time since recovery and pressure pain threshold (P . 0.05; r 5 20.049).
Discussion
This assessor-blinded quantitative study found that young females with long-standing PFP since adolescence were characterized by impaired CPM (reflecting less descending Figure 2 . Mean (195% CI) conditioning pain modulation (CPM) effect for the current-patellofemoral pain (current-PFP, solid bars), recovered-PFP (gray), and control (white) groups. Significantly different from recovered-PFP (*P , 0.005). CI, confidence interval; PDT, pain detection threshold; PTT, pain tolerance threshold. Table 2 Differences in threshold values on the test leg at baseline and during conditioning, and in VAS during temporal summation paradigm. pain inhibition) compared with the recovered-PFP group, facilitated TSP, and local and widespread pressure hyperalgesia compared to controls with no history of knee pain. The recovered-PFP group had a greater CPM effect compared with the current-PFP group. Interestingly, they had greater pressure pain sensitivity at the knee compared to controls with no history of knee pain, which was significantly decreased compared with the current-PFP group. Similarly, those with a history of knee pain displayed as much TSP as those currently experiencing persistent pain, which was increased relative to controls.
Pain mechanisms and patellofemoral pain
Previous smaller studies have demonstrated that patients with PFP are characterized by widespread pressure hyperalgesia and impaired CPM compared with healthy individuals. 28, 32 Interestingly, our results demonstrate that the recovered-PFP had a more efficient CPM compared to those with PFP. There were no differences for either of these groups from the healthy controls. Despite not reaching the intended sample size, small effect sizes between the current-PFP and controls (0.3 and 0.4 for CPM by detection and tolerance thresholds, respectively) supports the lack of differences in this cohort. The differences in CPM between recovered-PFP and current-PFP had a moderate effect size (0.7) supporting the statistical difference between these groups. The more efficient CPM in recovered-PFP compared with those who continue to suffer from pain is interesting and one could speculate if this could potentially be protective, acting as a "buffer" against pain, despite the fact that they display similarly facilitated TSP as those who have current-PFP. Indeed, this study is the first to also document facilitated TSP in female youth with PFP. Temporal summation of pain has extensively been investigated in older chronic pain populations, 3 but only one previous smaller study evaluated this in younger subjects with knee pain. 28 Despite the fact that participants were recruited from the same populationbased cohort (APA 2011) but at an earlier time point and not the same individuals (random selection), there was not a facilitated TSP profile in this earlier study. One reason for the differences may be relatively longer (2 years) symptom duration and greater disability in the current investigation, since measures of facilitated central pain mechanisms have been found to worsen with increasing pain duration. 5 Participants in this study scored worse on all subscales on the Knee Injury and Osteoarthritis Outcome Score than the previous study (most notably the sport subscale, which was 11 points lower), 28 and reported median pain duration of 8 years, which may be considered long (considering it is around 1/3 of their lives).
Previous research also indicates an association between pain duration and TSP in patients with knee osteoarthritis. 4 In patients with PFP, the lowest pressure pain thresholds were observed in those with the highest pain intensity and longest pain duration. 30 Further research is warranted to investigate "how long" patients with PFP need to have pain, before changes in pain sensitivity start to manifest, and whether early treatment affects the pain sensitivity and recurrent trajectory of pain.
The presence of long-standing pain, underpinned by increased pain sensitivity in these young adults, may also explain the high prevalence of additional pain sites in the current study (with 60% reporting pain in more than one location, and nearly 1 in 4 fulfilling the criteria for widespread pain). Having chronic musculoskeletal pain in one location is an independent risk factor for developing pain in subsequent other pain-free locations. 1 Although there are many potential contributors, central pain mechanisms are one potential reason thought to play a role. 15 Together, this may explain the mechanisms underpinning the unfavourable longerterm prognosis and trajectory toward more pain locations after developing PFP during adolescence.
Recovery from patellofemoral pain
The recurrent nature of PFP could be explained by increased pain sensitivity in the recovered-PFP group found in the current study. Despite being pain-free, it seems that changes in pain sensitivity and central pain mechanisms do not completely return to the level of controls, despite being recovered for a median of 24 months.
In knee osteoarthritis, a peripheral nociceptive drive has been considered important for maintaining facilitated central pain mechanisms, evidenced by the "normalisation" of mechanisms after "removal" of peripheral nociception by joint replacement surgery. 19, 20, 25 Contrary to this, the current investigation indicates that increased sensitivity persists in patients with PFP, despite self-reporting no current pain. This is in line with basic science indicating that development of central pain mechanisms initially depends on nociceptive inputs from peripheral injury, but that change can continue to persist in the absence of peripheral input. 1 Research from other recurrent musculoskeletal pain complaints provide alternative models/theories of pain recurrence. These have primarily focussed on biomechanics and altered motor control and postural stability in those with, eg, recurrent back pain, 22, 23 showing alterations despite symptom remission of symptoms. There is lack of data examining other factors (including pain sensitivity) in recurrent low back pain patients, and it is unclear if they display altered pain mechanisms relative to controls. 14, 35 No studies have evaluated biomechanics in patients with PFP despite no current pain.
This study is the first to demonstrate altered pain mechanisms in those with a previous history of adolescent PFP who are currently pain-free, providing the first potential mechanism for explaining their recurrent knee-pain episodes. The increased pain sensitivity and facilitated pronociceptive mechanisms in the recovered-PFP group means that minimal/reduced nociceptive input would be required for subsequent pain episodes to occur in this group. Dynamic processes influenced by past pain inputs or "somatosensory pain memories" may play a role. 13 Longitudinal research is needed to confirm this, and future research should try to prospectively elucidate the temporal profiles of pain mechanisms during recovery.
Strengths and limitations
Study strengths are the recruitment from a population-based cohort, increasing the generalizability of the results, and the use of a blinded assessor, reducing the risk of detection bias. A potential limitation is the cross-sectional nature of the study, preventing conclusions regarding causality of the observed findings. Exploring whether changes in local pain sensitivity were associated with time since recovery was not significant, but this analysis was limited by the small sample of recovered participants. Furthermore, we did not account for pain in other locations in the recovered group. The study was powered for 36 individuals per group. Unfortunately, few were recovered from knee pain, explaining the reduced recruitment and underlining the persistent nature of this pain complaint. Despite a lower sample size than expected, the data demonstrate clear findings, with the recovered group falling between controls and current pain on almost all outcomes.
Conclusion
Young females with long-standing PFP were characterized by widespread single-point pressure hyperalgesia and impaired descending pain control, whereas those who were currently painfree displayed increased localised pressure hyperalgesia and facilitated TSP compared with young pain-free females with no history of knee pain. Despite being recovered for a median of 2 years, those with a history of adolescent knee pain continue to demonstrate altered pain processing. These findings are particularly interesting due to the potential effects of such maintained effects on central pain mechanisms for recurrence of pain symptoms, despite reporting no current pain.
